Organic Active Ingredients TRIZ Cases

Substituted pyrrole and pyrazole compounds treat hematopoietic and solid tumors by activating the ATF4 pathway.

Merging oncolytic virus replication with Bcl-2 inhibition overcomes cancer resistance while sparing normal tissue.

1,4-disubstituted piperidine derivatives inhibit PDE5 enzyme activity to address invasive treatment limitations in erectile dysfunction therapy.

Cleavable groups on CSA prodrugs enable hydrolysis that converts inactive precursors into active antimicrobials, extending therapeutic windows and half-life.

REDD1 inhibitors dissociate therapeutic anti-inflammatory effects from adverse skin atrophy caused by glucocorticoid receptor agonists.

Compounds modulate utrophin expression to restore dystrophin-associated protein complex function and improve muscle integrity.

Mucoadhesive pullulan capsules deliver antiprogestins locally, reducing systemic side effects while maintaining therapeutic efficacy.

A mineralocorticoid receptor antagonist composition reduces particle size to 25 micrometers or less and incorporates surfactants to achieve high bioavailability.

Novel substituted triazole and imidazole derivatives modulate gamma-secretase activity through specific molecular structures.

Dry-heated polysaccharide nanogels resist side effects from conventional anticoagulants by binding thrombin with high affinity.

Crystallizing Cabazitaxel from triglycerides yields anhydrous form H, eliminating solvent volatility and polymorphic conversion risks.

Puromycin tagging links polypeptides to RNA transcripts, enabling selection of functional coding fragments.

Enzymatic hydrolysis of rice hulls yields a 56 to 103 kDa type II arabinogalactan that increases innate immune cell activity.

Hyaluronidase enzyme degrades subcutaneous hyaluronic acid to enhance anti-IL-6R antibody absorption and dispersion.

A PROTAC molecule degrades tyrosinase via the ubiquitin-proteasome system to reduce melanin production.

HER2 and HER3 inhibitors prevent ventilator-induced lung injury by moderating alveolar epithelial permeability.

Diamine oxidase removes accumulated histamine causing persistent fibromyalgia pain, addressing treatment gaps left by conventional antidepressants.

Modified oligonucleotides target TMPRSS6 mRNA to reduce protein expression levels in biological systems.

Cl-IB-MECA activates A3 adenosine receptors to deplete hepatic triglycerides, resolving NAFLD progression.

Titanium compounds catalyze diarylmethane reduction using alkali metal borohydride salts for efficient synthesis.

Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators stimulate somatostatin receptor expression on tumor cells.

Forskolin targets pre-adipocytes to inhibit adipogenesis and enhance brown adipose tissue recruitment factors.

Pyridine-free synthesis avoids thermal decomposition during purification, achieving high yield and purity for industrial production.

LMB64 bacterial extract blocks IL-1β and TNF-α production to resolve cutaneous neurogenic inflammation in sensitive skin.

A herbal composition from Mangifera indica bark, leaves, and fruit skin reduces body weight and lipid absorption.

Ionizable lipid nanoparticles encapsulate mRNA, while HPLC purification removes immunogenic contaminants to reduce immune response.

Periodate oxidation of dextran alters solubility properties, resolving the trade-off between water solubility and thickening capability.

Replaces synthetic NSAIDs with natural antioxidants to reduce oxidative damage while avoiding harmful side effects.

Fused heterocyclic compounds activate GPR120 receptors to improve glucose control while reducing side effects from existing diabetes treatments.

Engineered cysteine residues localize linker drug attachment to specific antibody positions.

Deuterium substitution at specific positions reduces addictive potential and constipation while maintaining strong analgesic potency for oral administration.

Compound of Formula III activates gp130 receptors to stimulate chondrocyte proliferation and cartilaginous matrix secretion.

A nicotine delivery product uses a cation exchange resin to bind nicotine within a controlled water range.

Salmonella-mediated oral DNA vaccination targets stable endothelial cells, bypassing tumor heterogeneity and MHC-loss limitations.

Novel pyrazolopyrimidines act as metabotropic glutamate 5 receptor antagonists.

Segmenting synthesis into discrete steps with preliminary purification ensures high drug purity while reducing production time and resource consumption.

Novel cyclic dinucleotides activate the STING receptor, inducing endogenous cytokines to overcome short half-life limitations of direct immunotherapy.

Novel spirolactams selectively inhibit Rho kinase activity to treat cardiovascular disorders.

Optimized emulsifier ratios maintain cream stability at high salt loads while enhancing percutaneous absorption rates.

Substituted 4-carboxamido-isoindolinone derivatives act as selective PARP-1 inhibitors.

Formula I aromatic compounds modulate HGF and MMP markers to enhance tissue repair, addressing insufficient growth stimulation in current treatments.

Polymeric matrix compositions with controlled viscosity prevent initial burst release, maintaining stable plasma levels for at least 14 days.

Fluorinated olefinic compound targets FGFR4 kinase to resolve selectivity and toxicity trade-offs.

Patsnap Eureka analyzes biomarker stratification using PSA monitoring to resolve treatment resource waste in prostate cancer.

USP19 inhibitors treat obesity and muscle wasting by blocking the USP19 enzyme to prevent protein degradation and improve insulin sensitivity.

Broth cube press compresses fluid granulate to ensure precise dosing while maintaining animal acceptance.

Kinase inhibitors block host cell kinases hijacked by SARS-CoV-2, reducing viral load and addressing ineffective traditional antiviral therapies.

Formula I compounds inhibit IDO and TDO enzymes, blocking tryptophan degradation and reducing immunosuppression in cancer treatment.

Monolithic anion exchange chromatography separates single-strand guanine-rich oligonucleotides from intact quadruplex structures.